197 related articles for article (PubMed ID: 3296761)
1. Phasic contraceptive pills and functional ovarian cysts.
Caillouette JC; Koehler AL
Am J Obstet Gynecol; 1987 Jun; 156(6):1538-42. PubMed ID: 3296761
[TBL] [Abstract][Full Text] [Related]
2. Ovarian function during low-dose oral contraceptive use.
Egarter C; Putz M; Strohmer H; Speiser P; Wenzl R; Huber J
Contraception; 1995 Jun; 51(6):329-33. PubMed ID: 7554971
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
Ayangade O; Akinyemi A
Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
[TBL] [Abstract][Full Text] [Related]
4. Enlarged follicles in women using oral contraceptives.
Broome M; Clayton J; Fotherby K
Contraception; 1995 Jul; 52(1):13-6. PubMed ID: 8521709
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive type and functional ovarian cysts.
Lanes SF; Birmann B; Walker AM; Singer S
Am J Obstet Gynecol; 1992 Mar; 166(3):956-61. PubMed ID: 1550172
[TBL] [Abstract][Full Text] [Related]
6. Comparative trials of low-dose combined oral contraceptives.
Edelman DA; Kothenbeutel R; Levinski MJ; Kelly SE
J Reprod Med; 1983 Mar; 28(3):195-200. PubMed ID: 6854550
[TBL] [Abstract][Full Text] [Related]
7. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
8. Histopathological and histochemical changes in the cervix uteri under contraceptive pills.
El Hakim SM; Abdin FH; Kandil O
Egypt Popul Fam Plann Rev; 1976 Dec; 10(2):20-33. PubMed ID: 12308408
[TBL] [Abstract][Full Text] [Related]
9. The probability of side effects with ovral, norinyl 1/50 and norlestrin.
Berger GS; Edelman DA; Talwar PP
Contraception; 1979 Nov; 20(5):447-53. PubMed ID: 160860
[TBL] [Abstract][Full Text] [Related]
10. Effects of contraceptive pills and intrauterine devices on urinary bladder.
Zahran MM; Osman MI; Kamel M; Fayad M; Mooro H; Youssef AF
Urology; 1976 Dec; 8(6):567-74. PubMed ID: 793141
[TBL] [Abstract][Full Text] [Related]
11. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
12. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
13. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and focal nodular hyperplasia of the liver.
Hagay ZJ; Leiberman RJ; Katz M; Witznitzer A
Arch Gynecol Obstet; 1988; 243(4):231-4. PubMed ID: 3223780
[TBL] [Abstract][Full Text] [Related]
15. Steroid contraceptives: neuro-psychiatric & electroencephalographic complications.
Elwan O; Madkour O; Kamal I; Abdallah M
J Int Med Res; 1973; 1(6):534-47. PubMed ID: 4806735
[TBL] [Abstract][Full Text] [Related]
16. Studies on ovarian function in users of the progestagen only contraceptive pill.
Tayob Y; Guillebaud J; Adams J; Jacobs HS
J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S91-5. PubMed ID: 12315277
[TBL] [Abstract][Full Text] [Related]
17. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
18. Detection and management of pathological, non-palpable, cystic adnexal masses.
Anderson RE; Serafini PC; Paulson RJ; Sauer MV; Marrs RP
Hum Reprod; 1990 Apr; 5(3):279-81. PubMed ID: 2141030
[TBL] [Abstract][Full Text] [Related]
19. Phasic approach to oral contraceptives.
Hale RW
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1052-8. PubMed ID: 3118718
[TBL] [Abstract][Full Text] [Related]
20. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
